维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

9篇 您的检索式：作者名="Precone"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus in- fection muhicenter Italian study 显示文摘	Caeta GB Stomaiuolo G Precone DF	2003	J Hepatol2003，39，：	1
	2	Epidemiologicaland clinical burden of chronic Hepatitis B virus/Hepatitis C virusinfection : A multicenter Italian study 显示文摘	Gaeta G B Stomaiuolo G Precone D F	2003	J Hepatol2003，39，6：	1
	3	Epideniological and clinical burden of chronichepatitis B virus/hepatitis C virusinfection a nulticenter italian study显示文摘	Gaeta GB Stornaiuole G Precone DF	2003	J Hepatol2003，39，7：	1
	4	DNA se- quence capture and next-generation sequencing for the molecular diagnosis of genetic cardiomyopathies 显示文摘	D'ARGENIO V FRISSO G PRECONE	2014	J Mol Diagn2014，16，：	1
	5	Epidemiological and clinical burden of chronic hepatitis B virus & hepatitis C virus infection multicenter Italian study显示文摘	Aeta GB Stomaiuolo G Precone DF	2003	J Hepato2003，39，6：	1
	6	DNA sequence capture and next-generation sequencing for the molecular diagnosis of genetic cardiomyopathies显示文摘	D'ARGENIO V FRISSO G PRECONE V	2014	J Mol Diagn2014，16，：	1
	7	Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC)显示文摘	Claudio Puoti Roberto Castellacci Fabrizio Montagnese Serena Zaltron Gianfranca Stornaiuolo Nicoletta Bergami Lia Bellis Davide F Precone Paolo Corvisieri Massimo Puoti Eliseo Minola Giovanni Battista Gaeta	2002	Journal of Hepatology2002，，1：	1
	8	Self-promotion?Intimate connections between APC and prostaglandin H synthase-2显示文摘	Precon SM Whtte RL	1996	Cell1996，87，5：	1
	9	Viral blips during long-term treatment with standard or double dose lamivudine in HBe antigen negative chronic hepatitis B显示文摘AIM:To evaluate safety and effect on hepatitis B virus(HBV)suppression of a long-term treatment with lamivudine(LAM)at standard(100 mg/d)or double(200 mg/d)dose in chronic hepatitis B.METHODS:This was a case study with matched controls(1:3)in patients with chronic hepatitis B with anti-HBe antibodies.RESULTS:Twelve patients received LAM 200 mg/d and 35 LAM 100 mg/d,for a median of 28 mo.A primary response(PR;i.e.negative HBV-DNA with Amplicor assay)was achieved in 100% of LAM-200 patients and 83% of LAM-100 patients.A virological breakthrough occurred in 16.7 and 24.7%,respectively,of the PR-patients,with the appearance of typical LAM resistance mutations in all but one patient.Viremia blips(i.e.transient HBV-DNA below 80 IU/mL in patients who tested negative at Amplicor assay)were detected using a real time polymerase chain reaction(PCR)and occurred in seven out of nine patients with subsequent BT and in four out of 32 patients with end-of-study response(77.7% vs 12.5%;P = 0.001)at chi-square test).At the end of the study,51.4% of LAM-100 patients and 83.3% of LAM-200 patients had remained stably HBV-DNA negative.Double-dose LAM was well tolerated.CONCLUSION:Long-term treatment of anti-HBe positive chronic hepatitis B with double dose lamivudine causes a more profound and stable viral suppression ascompared to conventional treatment.	Gianfranca Stornaiuolo Maria Stanzione Giuseppina Brancaccio Gianluca Cuomo Vincenza Precone Sebastiano Di Biase Francesca M Felaco Felice Piccinino Giovanni B Gaeta	2007	World Journal of Gastroenterology2007，13，42：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费